ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Eveliqure Announces NIAID Contract to Study Shigella, ETEC Vaccine Candidate americanpharmaceuticalreview
September 14, 2020Eveliqure Biotechnologies GmbH announced the award of a US government contract from the National Institute of Allergy and Infectious Diseases (NIAID), contract #75N93020C00048 with the intent to fund the development of its vaccine candidate, ShigETEC ...
Pharma Sources Insight January 2025
